Further analysis of the prognostic value of SOX9 expression in individuals with cancer revealed that overall survival was longer in ACC (Figure 3D) (adrenocortical carcinoma) and shorter in LGG (Figure 3E), CESC (Figure 3F), and THYM (Figure 3G) when SOX9 was highly expressed in pan-cancer compared with the matched healthy tissues. The gene discussed is SOX9; the disease is adrenal cortex carcinoma.